A Wealth of Experience

We have collaborated with our clients on projects to research vaccines for various diseases.  Our experience includes: 

  • Cholera
  • Dengue fever
  • Hepatitis
  • Human papillomavirus (HPV)
  • Influenza (including H1N1)
  • Malaria
  • Measles
  • Meningococcal, conjugate (including MCV4)
  • Meningococcal, polysaccharide (MPSV4)
  • Mumps
  • Pertussis
  • Pneumococcal conjugate (PCV)
  • Pneumococcal polysaccharide (PPSV)
  • Respiratory syncytial virus (RSV)
  • Rotavirus
  • Rubella
  • Staphylococcus aureus
  • Tetanus, diphtheria (Td)
  • Tetanus, diphtheria, and pertussis (Tdap)
  • Typhoid
  • Typhoid fever
  • Varicella
  • Zoster

Types of Projects

We have implemented studies to help our clients develop strategies in the vaccine market and to develop and gain market access for vaccines to prevent various diseases.  Recent project types have included:

Our Experts

Sandra Talbird
Senior Director, Health Economics
Jin Yang
Sr. Associate, Market Access and Outcomes Strategy
Bintu Sherif
Senior Statistician
Jonathan Graham
Director, Health Economics
Keith Davis
Senior Director, Health Economics
Josephine Mauskopf
Vice President, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Will Herring
Director, Health Economics
Christine Poulos
Senior Research Economist
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Katherine Hicks
Director, Health Economics
Kelly Hollis
Global Head, Surveys and Observational Studies
Samantha Kurosky
Director, Health Economics

Selected Recent Vaccines Publications